CEO: Italy-made Sputnik V aimed for EU market, if approved
CEO: Italy-made Sputnik V aimed for EU market, if approved COLLEEN BARRY, Associated Press FacebookTwitterEmail 5 1of5A view of the Adienne Srl plant pharmaceutical company in Caponago, near Milan, Italy, Tuesday, March 9, 2021. Russia signed a deal to produce 10 million doses of the Sputnik V coronavirus vaccine in Italy this year. The deal was announced by the Italian-Russian chamber of commerce and signed by Adienne Srl, the Italian subsidiary of a Swiss-based pharmaceutical com...
Russian Chamber European Medicines Agency Italian Medicines Agency Russian Direct Investment Fund Swiss Based Adienne Pharma Russian Direct Investment
Source: sfgate.com